Vice President (VP) Operations

At FimmCyte Therapeutics, an innovative leader in biotech, we are seeking a dynamic and experienced Vice President of Operations focusing on advancing a novel molecule from development candidate to IND approval and beyond. Our company, with a close-knit team is committed to advancing cutting-edge therapeutics for large unmet needs. As VP of Operations, you will independently drive our endometriosis program through non-clinical development and CMC to ensure the successful progression towards the clinic. This position offers a unique opportunity to experience how a fast paced biotech operates with direct access to executives and the board. That in addition to the chance to drive the end-to-end development process of a novel molecule towards the clinic.TasksLead overall execution of advancing our antibody program from development candidate (DC) to IND approvalDirect and oversee CMC, non-clinical safety, pharmacology, pharmacokinetics, and toxicology studies.Manage and build relationships with global CROs and CDMOsEnsure effective outsourcing strategies, vendor qualification, contract negotiations, and long-term partnerships.Interface with potential pharma partners to ensure the timely delivery of milestonesDrive effective program timelines, resource allocation, and strong project management execution.Manage regulatory requirements in US, EU, and Australia.RequirementsMinimum 10 years of experience in project management in small to medium biotech or pharmaceutical organizations, >15 years preferred>5 years Experience in biologics non-clinical development and CMCMinimum 2 previous programs taken from DC to IND approvalProven experience managing CROs and CDMOs globallyStrong project management background with demonstrated ability to deliver results on-time and within scope.Strongly independent, can-do attitude, detail oriented, striving for maximum quality, speed and cost efficiency.Willing to travel 20% of the time in the EU, US, and ChinaValid work authorization in Switzerland100% Workload onlyImmediately or January/2026 startBenefitsStartup team with daily direct access to the executive teamCompetitive compensation with stock option planFlexible working hours and location